CFD
OPRX icon

Creative Financial Designs’s OptimizeRx OPRX Stock Holding History

Creative Financial Designs’s Portfolio OPRX Stock Details OPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-191
Closed -$2.32K – 1700
2024
Q1 		$2.32K Buy
+191
New +$2.77K ﹤0.01% 1468

Other funds holding OPRX

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SM
Samjo Management New York $231M AUM 13.04% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GIPM
G2 Investment Partners Management New York $406M AUM 164.47% 1-Year Est. Return

Creative Financial Designs's OPRX Position: Q2 2024 in Review

Creative Financial Designs sold out of OptimizeRx (OPRX) in Q2 2024, closing a stake of 191 shares — an estimated $2.32K sold.

Creative Financial Designs first reported a position in OPRX in Q1 2024 and held it in 1 quarter. The position peaked at $2.32K in Q1 2024. 92 funds tracked by Wall St. Rank hold OPRX as of Q2 2024.

  • Creative Financial Designs reported no remaining OptimizeRx position as of Q2 2024 after selling out during the quarter.
  • Creative Financial Designs sold 191 OptimizeRx shares in Q2 2024, an estimated $2.32K.
  • Creative Financial Designs first reported a position in OptimizeRx in Q1 2024 and held it in 1 quarter.
  • Creative Financial Designs's OptimizeRx position peaked at $2.32K in Q1 2024.
  • 92 funds tracked by Wall St. Rank held OptimizeRx as of Q2 2024.

Based on Creative Financial Designs's 13F filing for Q2 2024, filed 6 Aug 2024.